PFKFB4 and glioblastoma: In a previous study, we have shown that PFKFB4 is upregulated in GSCs compared to normal brain, and that its silencing leads to apoptotic cell death in GSCs [18], highlighting its potential as a therapeutic target in glioblastoma.